Andre Lamy

Dr. Andre Lamy is a cardiac surgeon and a Professor in the Department of Surgery at McMaster University. He is also a scientist at the Population Health Research Institute in Hamilton.

Dr. Lamy was the PI of the CORONARY trial, a large multi centered randomized trial of off-pump CABG surgery versus on-pump CABG surgery. Dr. Lamy is also leading the COMPASS-CABG, a RCT evaluating the benefits of rivaroxaban for graft patency after CABG surgery as well as VISION-Cardiac surgery, a prospective analysis of 15,000 patients to determine the cut-off value and prognostic factor of high sensitivity troponin essays after cardiac surgery. Dr. Lamy also has expertise in health economics and published for COMPASS, TIPS-3, HOPE-3 and more.